Kimberly-Clark elects Joseph Romanelli to board of directors, effective immediately

KIMBERLY CLARK CORP

Romanelli, 51, appointed as independent director and to the Audit Committee; board expands from 12 to 13 members.
He serves as President of Human Health International for Merck & Co., Inc. (MSD).
Romanelli brings global leadership experience in biopharmaceuticals and international markets.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Joseph Romanelli

independent member of the Board

KMB · KIMBERLY CLARK CORP

Effective: 2024-11-13
Filed: November 13, 2024, 6:59 PM ET

On November 13, 2024, the Board of Directors (the “Board”) of Kimberly-Clark Corporation (the “Corporation”) elected Joseph Romanelli, 51, as an independent member of the Board

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Joseph Romanelli was elected as independent member of the Board at KIMBERLY CLARK CORP.

Action: elected
Role: independent member of the Board

Exact text from the filing

On November 13, 2024, the Board of Directors (the “Board”) of Kimberly-Clark Corporation (the “Corporation”) elected Joseph Romanelli, 51, as an independent member of the Board

View on SEC.gov

KIMBERLY CLARK CORP filing history →

Source: SEC EDGAR

accession 0000055785-24-000098

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.